Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2009

View Archived Issues

Durasphere bulking agent effective for recurrent pyelonephritis in kidney transplant patients

Duquesne University discloses novel tricyclic compounds for cancer treatment

New heterocyclic compounds in early development at AstraZeneca for the treatment of cancer

Shanghai Hengrui describes new protein kinase inhibitors in early development

GSK researchers describe new histamine H3 receptor antagonists for cognitive impairment

Merck & Co. claims new guanylate cyclase activators for the treatment of hypertension

Siga presents novel antiviral drugs active against hemorrhagic fever viruses

Exenatide induces weight loss and glucose normalization in nondiabetic obese patients

Alseres receives SPA agreement from FDA for phase III Altropane trial

Intercell initiates phase I Streptococcus pneumoniae vaccine trial

Seattle Genetics enters antibody-drug conjugate collaboration with Millennium

Positive phase II findings for Reolysin with radiation in advanced cancers

Watson launches Rapaflo

Novel JAK1/JAK2 inhibitor developed by Cytopia for the treatment of myeloproliferative disorders

Danisco BioActives and Sigma-Tau collaborate on necrotizing enterocolitis drug

Serentis starts phase II first-in-class SRD-441 study for eczema

FDA accepts Theravance's telavancin NDA for hospital-acquired pneumonia

Genta completes patient enrollment in global phase III Genasense trial

Health Canada approves once-daily Prezista as part of combination HIV therapy

TRITON-TIMI 38 data on prasugrel in acute coronary syndromes further analyzed

Aplenzin extended-release tablets available in the U.S.

Cardiovascular risk with PPAR agonist aleglitazar assessed in diabetes patients

FDA Advisory Committee provides opinion on Serdolect in schizophrenia

Daiichi Sankyo and Eli Lilly launch Efient in the U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...